Announcement on the Compliance of the First Vesting Period of the 2025 Restricted Stock Incentive Plan
Beijing Ruimait Medical Technology Co., Ltd. (hereinafter referred to as "the Company" or "this Company") and all members of the Board of Directors guarantee that the content of this information disclosure is true, accurate, and complete, without any false records, misleading statements, or major omissions.
Important Content Reminder:
- Number of eligible incentive recipients: 52 individuals
- Number of restricted shares to be vested: 338,569 shares
- Source of vested shares: Company A shares repurchased from the secondary market
- Grant price: 38.26 yuan/share (adjusted)
- The Company will issue a related announcement regarding the listing and circulation of the vested restricted shares after completing the relevant procedures. Investors are advised to pay attention.
On April 22, 2026, the Company held the 19th meeting of the third Board of Directors, which reviewed and approved the proposal regarding the compliance of the first vesting period of the 2025 Restricted Stock Incentive Plan. The Board believes that the vesting conditions for the first vesting period of the 2025 Restricted Stock Incentive Plan have been met and agrees to process the vesting of 338,569 shares of the second category of restricted stock for the 52 eligible incentive recipients.
According to the provisions of the "2025 Restricted Stock Incentive Plan (Draft)" (hereinafter referred to as "the Incentive Plan" or "this Incentive Plan") and the authorization from the first extraordinary general meeting of shareholders in 2025, the specific situation is announced as follows:
I. Overview of the Incentive Plan and Related Approval Procedures
(1) Overview of the Incentive Plan
- Incentive tool: Second category of restricted stock.
- Source of underlying shares: Company A shares repurchased from the secondary market and/or A shares issued to incentive recipients.
- Grant price: 38.26 yuan/share (adjusted).
- Scope and distribution of incentive recipients: A total of 54 individuals are included in this incentive plan, consisting of senior management and core technical (business) personnel employed by the Company (including its holding subsidiaries). The incentive recipients do not include independent directors, supervisors, or shareholders holding 5% or more of the Company's shares, or their spouses, parents, children, and foreign employees. The details are as follows:
| Name | Position | Number of Restricted Shares Granted (10,000 shares) | Proportion of Total Grant | Proportion of Total Share Capital at Draft Announcement |
|---|---|---|---|---|
| Bao Nan | Deputy General Manager, CFO | 2.20 | 3.13% | 0.02% |
| Zheng Fang | Deputy General Manager | 2.20 | 3.13% | 0.02% |
| Core Technical (Business) Personnel (52 individuals) | 66.00 | 93.75% | 0.74% | |
| Total | 70.40 | 100.00% | 0.79% |
Note:
- None of the above incentive recipients have been granted shares exceeding 1% of the Company's total share capital through all effective equity incentive plans. The total number of underlying shares involved in all effective incentive plans does not exceed 20% of the Company's total share capital at the time of submission to the shareholders' meeting.
- The incentive recipients do not include independent directors, supervisors, or shareholders holding 5% or more of the Company's shares, or their spouses, parents, children, and foreign employees.
- Any discrepancies in totals in the above table are due to rounding.